Search clinical trials for: Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Total 442543 results
-
Istituto Scientifico Romagnolo per lo Studio e...CompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastItaly
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastItaly
-
Borstkanker Onderzoek GroepRoche Pharma AG; Teva PharmaCompletedMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastNetherlands
-
University of ChicagoNot yet recruitingBreast Cancer | HER2-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
NovartisCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast CancerUnited States
-
Kirsehir Ahi Evran UniversitesiRecruitingLymphedema, Breast CancerTurkey
-
Cardiovascular and Interventional Radiological...CompletedNeoplasm Metastasis | Colorectal CarcinomaAustria
-
Kasr El Aini HospitalCompleted
-
McMaster UniversityCanadian Breast Cancer FoundationCompletedBreast Cancer Invasive Nos | Stage 0 Breast CarcinomaCanada
-
Dana-Farber Cancer InstitutePfizerCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor (HR)-Positive Breast CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
Dana-Farber Cancer InstituteEisai Inc.Active, not recruitingInflammatory Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
MedSIRPfizerCompletedBreast Cancer | Advanced Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain, Germany, France, United Kingdom, Italy, Slovenia
-
Helwan UniversityNot yet recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone-receptor-positive Breast Cancer
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
Eisai Inc.Active, not recruitingBreast Neoplasms | Receptors, Estrogen | Genes, Erbb-2United States, United Kingdom
-
Rush University Medical CenterCompletedAdvanced Breast Cancer | Metastatic Breast Cancer | Estrogen Receptor-positive Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
Mersin UniversityRecruiting
-
Necmi Kadıoğlu HospitalRecruitingChildren | Hypospadias | Hypospadias, Coronal | Caudal AnesthesiaNorth Macedonia, Russian Federation, Turkey
-
Pirogov Russian National Research Medical UniversityRecruitingPrimary Inguinal HerniaRussian Federation
-
Jennifer KeiserCentre Suisse de Recherches Scientifiques en Cote d'IvoireCompletedHookworm Infections | TrichuriasisCôte D'Ivoire
-
Pamukkale UniversityCompletedHearing Loss, SensorineuralTurkey
-
Ankara Medipol UniversityCompletedHealth Behavior | Healthy LifestyleTurkey
-
Tanta UniversityCompletedPeriodontal DiseasesEgypt
-
Parc de Salut MarCompletedCancer of Stomach | Cancer of EsophagusSpain
-
Ain Shams UniversityCompletedEndometrial ThicknessEgypt
-
Conde, Bebiana, M.D.Completed
-
Federal University of São PauloUnknown
-
University of Sao PauloRDO LaboratoryUnknown
-
Zagazig UniversityUnknownSecond Trimester AbortionEgypt
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownBreast Cancer | Metastatic Breast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Locally Advanced Malignant NeoplasmItaly
-
Rigshospitalet, DenmarkNot yet recruitingBreast Cancer Female
-
Hannover Medical SchoolGerman Center for Infection ResearchRecruiting
-
Heidelberg UniversityGerman Research FoundationCompleted
-
Cairo UniversityUnknown
-
Centro Nacional de Investigaciones Oncologicas...Fundacion CRIS de Investigación para Vencer el CáncerCompletedBreast Cancer | Early-Stage Breast Carcinoma | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastSpain
-
Akdeniz UniversityRecruiting
-
SangathHarvard Medical School (HMS and HSDM); London School of Hygiene and Tropical...CompletedMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)India
-
Incyclix BioRecruitingBreast Cancer | Ovarian Cancer | Solid Tumor | Metastatic Cancer | Advanced Cancer | Breast Cancer Metastatic | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | CCNE1 AmplificationUnited States, Australia
-
Changzhou No.2 People's HospitalNot yet recruitingNon-small Cell Lung Cancer
-
University of ArizonaNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastUnited States
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
European Organisation for Research and Treatment...Hoffmann-La Roche; UNICANCER; Janssen Diagnostics, LLC; SUCCESSCompletedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Circulating Tumor CellsFrance, Germany, Belgium, United Kingdom
-
Chugai PharmaceuticalJapan Lung Cancer SocietyCompletedNon-small Cell Lung Cancer | Extensive Disease Small Cell Lung CancerJapan
-
Chinese PLA General HospitalUnknownAdvanced HER-2 Positive Solid Tumors | Chemotherapy Refactory | HER-2 Antibody Inhibitor Therapy RefactoryChina
-
Novartis PharmaceuticalsCompletedBreast CancerBelgium, Hungary, Spain, Argentina, Russian Federation, Sweden, Lebanon, Australia, Denmark, Ireland, United Kingdom, Thailand, Turkey, Peru, Brazil, Malaysia, India, United States